BRAF and melanoma: Recently, a large clinical study analyzed ctDNA isolated from plasma samples obtained at baseline from 556 patients with BRAF V600E/K SNV positive melanoma who were enrolled in BREAK-2 [73], BREAK-3 [74], BREAK-MB [75], and METRIC [76] studies.